ask="7.75"
ask_size="100"
average_daily_volume="985173"
bid="5.21"
bid_size="100"
book_value="0.05"
change="-0.11"
change_from_200_day_moving_average="0.24"
change_from_50_day_moving_average="-0.58"
change_from_52_week_high="-2.07"
change_From_52_week_low="3.60"
change_in_percent="-1.96%"
close="5.49"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="46578000"
high="5.61"
high_52_weeks="7.56"
last_trade_date="2/24/2017"
last_trade_price="5.49"
last_trade_size="50057"
last_trade_time="4:00pm"
low="5.37"
low_52_weeks="1.89"
market_capitalization="404.93M"
moving_average_200_day="5.25"
moving_average_50_day="6.07"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.10"
open="5.50"
pe_ratio="N/A"
peg_ratio="-0.31"
percent_change_from_200_day_moving_average="+4.50%"
percent_change_from_50_day_moving_average="-9.60%"
percent_change_from_52_week_high="-27.38%"
percent_change_from_52_week_low="+190.48%"
previous_close="5.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="103.70"
price_per_sales="18.80"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="1367156"
weeks_range_52="1.89 - 7.56"
